Literature DB >> 19127427

Comparison of letrozole with continuous gonadotropins and clomiphene-gonadotropin combination for ovulation induction in 1387 PCOS women after clomiphene citrate failure: a randomized prospective clinical trial.

Ashalatha Ganesh1, Sourendra Kant Goswami, Ratna Chattopadhyay, Koel Chaudhury, Baidyanath Chakravarty.   

Abstract

PURPOSE: Letrozole, though reported to be an effective ovulation inducing agent, warrants larger randomized trials. The purpose of this study is to compare the efficacy of letrozole with that of rFSH and clomiphene citrate(CC)/rFSH for ovarian stimulation in IUI cycles.
METHODS: Randomized, prospective, single-blinded clinical trial. 1387 PCOS women after CC failure were randomized into three groups: Group A received letrozole, Group B received CC with two doses rFSH and Group C received continuous rFSH day 2 onwards until hCG injection.
RESULTS: Group A, B and C had an ovulation rate of 79.30%, 56.95% and 89.89% and cycle cancellation rate of 20.70%, 43.05% and 10.11%, respectively. Pregnancy rates in Group A, B and C were 23.39%, 14.35% and 17.92%, while the miscarriage rates were 13.80%, 16.67% and 14.52%, respectively.
CONCLUSION: Letrozole appears to be a suitable ovulation inducing agent in PCOS women with CC failure and is found to be most effective when baseline estradiol level >60 pg/ml.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19127427      PMCID: PMC2649330          DOI: 10.1007/s10815-008-9284-4

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  29 in total

1.  A randomized single-blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: a preliminary report.

Authors:  S K Goswami; T Das; R Chattopadhyay; V Sawhney; J Kumar; K Chaudhury; B N Chakravarty; S N Kabir
Journal:  Hum Reprod       Date:  2004-06-24       Impact factor: 6.918

2.  Comparison of the efficacy of the aromatase inhibitor letrozole and clomiphene citrate as adjuvants to recombinant follicle-stimulating hormone in controlled ovarian hyperstimulation: a prospective, randomized, blinded clinical trial.

Authors:  Gerardo Barroso; Gerardo Menocal; Hector Felix; Juan Carlos Rojas-Ruiz; Murat Arslan; Sergio Oehninger
Journal:  Fertil Steril       Date:  2006-09-14       Impact factor: 7.329

3.  A randomized clinical trial of clomiphene citrate versus low dose recombinant FSH for ovarian hyperstimulation in intrauterine insemination cycles for unexplained and male subfertility.

Authors:  T Dankert; J A M Kremer; B J Cohlen; C J C M Hamilton; P C M Pasker-de Jong; H Straatman; P A van Dop
Journal:  Hum Reprod       Date:  2006-11-16       Impact factor: 6.918

4.  Cost-effectiveness of aromatase inhibitor co-treatment for controlled ovarian stimulation.

Authors:  Mohamed A Bedaiwy; Rachel Forman; Noha A Mousa; Hesham G Al Inany; Robert F Casper
Journal:  Hum Reprod       Date:  2006-07-27       Impact factor: 6.918

5.  Future use of clomiphene in ovarian stimulation. Will clomiphene persist in the 21st century?

Authors:  B C Tarlatzis; G Grimbizis
Journal:  Hum Reprod       Date:  1998-09       Impact factor: 6.918

6.  Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate.

Authors:  M F Mitwally; R F Casper
Journal:  Fertil Steril       Date:  2001-02       Impact factor: 7.329

7.  Use of an aromatase inhibitor in patients with polycystic ovary syndrome: a prospective randomized trial.

Authors:  Ulkü Bayar; Mustafa Basaran; Sibel Kiran; Ayhan Coskun; Sener Gezer
Journal:  Fertil Steril       Date:  2006-11       Impact factor: 7.329

8.  Aromatase inhibition reduces gonadotrophin dose required for controlled ovarian stimulation in women with unexplained infertility.

Authors:  M F M Mitwally; R F Casper
Journal:  Hum Reprod       Date:  2003-08       Impact factor: 6.918

9.  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.

Authors: 
Journal:  Fertil Steril       Date:  2004-01       Impact factor: 7.329

10.  Sequential clomiphene citrate and human menopausal gonadotrophin with intrauterine insemination: the effect of patient age on clinical outcome.

Authors:  P R Brzechffa; S Daneshmand; R P Buyalos
Journal:  Hum Reprod       Date:  1998-08       Impact factor: 6.918

View more
  15 in total

1.  Gonadotropin Alone is a Better Drug for Ovarian Stimulation than in Combination with Clomiphene in Intrauterine Insemination.

Authors:  Sushma Sinha; Neha Agrawal
Journal:  J Obstet Gynaecol India       Date:  2015-03-13

Review 2.  Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.

Authors:  Sebastian Franik; Quang-Khoi Le; Jan Am Kremer; Ludwig Kiesel; Cindy Farquhar
Journal:  Cochrane Database Syst Rev       Date:  2022-09-27

3.  Comparative evaluation of pregnancy outcome in gonadotrophin-clomiphene combination vs clomiphene alone in polycystic ovarian syndrome and unexplained infertility-A prospective clinical trial.

Authors:  Shiuli Mukherjee; Sunita Sharma; B N Chakravarty
Journal:  J Hum Reprod Sci       Date:  2010-05

4.  Letrozole in a low-cost in vitro fertilization protocol in intracytoplasmic sperm injection cycles for male factor infertility: A randomized controlled trial.

Authors:  Shiuli Mukherjee; Sunita Sharma; Baldya Nath Chakravarty
Journal:  J Hum Reprod Sci       Date:  2012-05

5.  A prospective randomized trial comparing the efficacy of Letrozole and Clomiphene citrate in induction of ovulation in polycystic ovarian syndrome.

Authors:  Kallol Kumar Roy; Jinee Baruah; Shilpa Singla; Jai Bhagwan Sharma; Neeta Singh; Sunesh Kumar Jain; Manu Goyal
Journal:  J Hum Reprod Sci       Date:  2012-01

Review 6.  Aromatase inhibitors (letrozole) for subfertile women with polycystic ovary syndrome.

Authors:  Sebastian Franik; Stephanie M Eltrop; Jan Am Kremer; Ludwig Kiesel; Cindy Farquhar
Journal:  Cochrane Database Syst Rev       Date:  2018-05-24

7.  The Effect of Prenatal Treatments on Offspring Events in the Presence of Competing Events: An Application to a Randomized Trial of Fertility Therapies.

Authors:  Yu-Han Chiu; Mats J Stensrud; Issa J Dahabreh; Paolo Rinaudo; Michael P Diamond; John Hsu; Sonia Hernández-Díaz; Miguel A Hernán
Journal:  Epidemiology       Date:  2020-09       Impact factor: 4.860

8.  Comparison of letrozole versus tamoxifen effects in clomiphen citrate resistant women with polycystic ovarian syndrome.

Authors:  Mohamed Nabih El-Gharib; Amal Elsayed Mahfouz; Manal Abdelraouf Farahat
Journal:  J Reprod Infertil       Date:  2015 Jan-Mar

9.  Clomiphene citrate or letrozole as first-line ovulation induction drug in infertile PCOS women: A prospective randomized trial.

Authors:  Sujata Kar
Journal:  J Hum Reprod Sci       Date:  2012-09

10.  Comparison of the effectiveness of clomiphene citrate, tamoxifen and letrozole in ovulation induction in infertility due to isolated unovulation.

Authors:  Fariba Seyedoshohadaei; Farnaz Zandvakily; Shole Shahgeibi
Journal:  Iran J Reprod Med       Date:  2012-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.